C1ORF135 expression based on
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Comparison | Statistical significance |
Normal-vs-Primary | 3.467800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.385180E-01 |
Normal-vs-Stage2 |
3.955000E-01 |
Normal-vs-Stage3 |
9.406500E-02 |
Normal-vs-Stage4 |
4.797200E-01 |
Stage1-vs-Stage2 |
9.378600E-01 |
Stage1-vs-Stage3 |
1.993680E-02 |
Stage1-vs-Stage4 |
3.773800E-01 |
Stage2-vs-Stage3 |
7.466200E-02 |
Stage2-vs-Stage4 |
3.018600E-01 |
Stage3-vs-Stage4 |
5.338600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.759000E-01 |
Normal-vs-AfricanAmerican |
1.953680E-02 |
Normal-vs-Asian |
4.809000E-01 |
Caucasian-vs-AfricanAmerican |
1.687600E-01 |
Caucasian-vs-Asian |
3.794800E-01 |
AfricanAmerican-vs-Asian |
2.725800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.541720E-03 |
Normal-vs-Female |
1.287000E-01 |
Male-vs-Female |
1.203850E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.505210E-01 |
Normal-vs-Extreme_Weight |
1.409110E-04 |
Normal-vs-Obese |
6.754800E-01 |
Normal-vs-Extreme_Obese |
1.211280E-04 |
Normal_Weight-vs-Extreme_Weight |
1.019450E-01 |
Normal_Weight-vs-Obese |
5.917400E-01 |
Normal_Weight-vs-Extreme_Obese |
1.735640E-02 |
Extreme_Weight-vs-Obese |
8.745900E-02 |
Extreme_Weight-vs-Extreme_Obese |
2.554800E-01 |
Obese-vs-Extreme_Obese |
2.032500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.142020E-01 |
Normal-vs-Age(41-60Yrs) |
2.720400E-01 |
Normal-vs-Age(61-80Yrs) |
2.830800E-01 |
Normal-vs-Age(81-100Yrs) |
6.770600E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.034000E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.842200E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.570020E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.581400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.870200E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.465390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.202280E-04 |
Normal-VS-Type2 PRCC |
7.495700E-03 |
Normal-VS-KIRP CIMP |
2.676500E-03 |
Normal-VS-Unclassified PRCC |
2.059600E-02 |
Type1 PRCC-VS-Type2 PRCC |
9.291200E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.298260E-03 |
Type1 PRCC-VS-Unclassified PRCC |
7.685400E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.355650E-03 |
Type2 PRCC-VS-Unclassified PRCC |
7.632800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.481950E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.449800E-01 |
Normal-vs-N1 |
1.314340E-02 |
Normal-vs-N2 |
6.419400E-01 |
N0-vs-N1 |
7.036400E-03 |
N0-vs-N2 |
4.298600E-01 |
N1-vs-N2 |
4.355200E-01 |
|
|